Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.34 USD | +0.47% | -0.85% | -8.47% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.47% | 17.92B | |
-5.33% | 182B | |
+4.04% | 114B | |
-3.20% | 68.38B | |
+5.65% | 52.46B | |
+8.15% | 44.25B | |
+7.52% | 43.55B | |
+24.54% | 32.69B | |
+17.85% | 26.73B | |
-0.35% | 25.79B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Baxter International Names Joel Grade Finance Chief